BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32678691)

  • 1. Does Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive Improve Endometriosis-Associated Chronic Pelvic Pain in Women?
    Caruso S; Cianci A; Iraci M; Fava V; Di Pasqua S; Cianci S
    J Womens Health (Larchmt); 2020 Sep; 29(9):1184-1191. PubMed ID: 32678691
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain.
    Caruso S; Cianci A; Iraci Sareri M; Panella M; Caruso G; Cianci S
    BMC Womens Health; 2022 May; 22(1):146. PubMed ID: 35538479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
    Caruso S; Iraci M; Cianci S; Fava V; Casella E; Cianci A
    J Endocrinol Invest; 2016 Aug; 39(8):923-31. PubMed ID: 27023105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of Low Sexual Desire Due to Antiandrogenic Combined Oral Contraceptives After Switching to an Oral Contraceptive Containing 17β-Estradiol.
    Caruso S; Cianci S; Cariola M; Fava V; Di Pasqua S; Cianci A
    J Womens Health (Larchmt); 2017 Jul; 26(7):728-734. PubMed ID: 28323519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest.
    Caruso S; Iraci M; Cianci S; Casella E; Fava V; Cianci A
    J Endocrinol Invest; 2015 Nov; 38(11):1211-8. PubMed ID: 26337183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
    Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
    Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and α-lipoic acid.
    Caruso S; Iraci Sareri M; Casella E; Ventura B; Fava V; Cianci A
    Minerva Ginecol; 2015 Oct; 67(5):413-9. PubMed ID: 26491823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain.
    Caruso S; Iraci M; Cianci S; Vitale SG; Fava V; Cianci A
    J Pain Res; 2019; 12():2371-2378. PubMed ID: 31536046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea.
    Fox MC; Klipping C; Nguyen AM; Frenkl TL; Cruz SM; Wang Y; Korver T
    Contraception; 2019 Feb; 99(2):125-130. PubMed ID: 30439359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol/nomegestrol acetate as a first-line and rescue therapy for the treatment of ovarian and deep infiltrating endometriosis.
    Mariani LL; Novara L; Mancarella M; Fuso L; Casula E; Biglia N
    Gynecol Endocrinol; 2021 Jul; 37(7):646-649. PubMed ID: 33749482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
    Gaussem P; Alhenc-Gelas M; Thomas JL; Bachelot-Loza C; Remones V; Ali FD; Aiach M; Scarabin PY
    Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study.
    Christin-Maitre S; Serfaty D; Chabbert-Buffet N; Ochsenbein E; Chassard D; Thomas JL
    Hum Reprod; 2011 Jun; 26(6):1338-47. PubMed ID: 21421664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results].
    Lo Monte G; Soave I; Marci R
    Minerva Ginecol; 2013 Aug; 65(4):453-63. PubMed ID: 24051945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO).
    Cagnacci A; Bastianelli C; Neri M; Cianci A; Benedetto C; Calanni L; Vignali M; De Leo V; Cicinelli E; Borrelli G; Volpe A;
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):393-399. PubMed ID: 30465698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC).
    Neri M; Malune ME; Corda V; Piras B; Zedda P; Pilloni M; Orani MP; Vallerino V; Melis GB; Paoletti AM
    Gynecol Endocrinol; 2017 Dec; 33(12):958-962. PubMed ID: 28485628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of nomegestrol acetate pharmacokinetics in healthy female adolescents and adults by whole-body physiology-based pharmacokinetic modelling and clinical validation.
    Post TM; Gerrits M; Kerbusch T; de Greef R
    Contraception; 2016 Feb; 93(2):133-8. PubMed ID: 26365792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
    Vercellini P; De Giorgi O; Oldani S; Cortesi I; Panazza S; Crosignani PG
    Am J Obstet Gynecol; 1996 Aug; 175(2):396-401. PubMed ID: 8765259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial.
    de Kam PJ; van Kuijk J; Lillin O; Post T; Thomsen T
    Clin Drug Investig; 2014 Jun; 34(6):413-20. PubMed ID: 24777591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.